Literature DB >> 25155590

Culture of the entire mouse to determine whether cultivable Borrelia burgdorferi persists in infected mice treated with a five-day course of Ceftriaxone.

Charles S Pavia1, Gary P Wormser2.   

Abstract

Although controversial, it has been suggested that antibiotic treatment of laboratory animals infected with Borrelia burgdorferi often leads to the persistence of residual spirochetes that are claimed to be viable but noncultivable. If viable cells of B. burgdorferi do persist following antibiotic therapy, one possible explanation for the lack of cultivability is that too few organisms persist in any given tissue site that might be sampled and cultured. In this study, we treated SKH (hairless) mice, with B. burgdorferi infection of 3 months' duration, with either ceftriaxone or saline for 5 days and then cultured a suspension extract of nearly the entire mouse using a combined in vivo/in vitro culture method. All of the saline-treated (control) mice were culture positive, compared with none of the antibiotic-treated mice. Our findings further document the effectiveness of antibiotic therapy in eradicating cultivable cells of B. burgdorferi, irrespective of tissue or organ site.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25155590      PMCID: PMC4249442          DOI: 10.1128/AAC.03751-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents.

Authors:  R C Johnson; C B Kodner; P J Jurkovich; J J Collins
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

2.  Efficacy of short-course ceftriaxone therapy for Borrelia burgdorferi infection in C3H mice.

Authors:  Charles Pavia; Mario A Inchiosa; Gary P Wormser
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

Review 3.  Antibiotic treatment of animals infected with Borrelia burgdorferi.

Authors:  Gary P Wormser; Ira Schwartz
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

4.  Intermittent spirochetemia in SKH mice infected with Borrelia burgdorferi, sensu stricto.

Authors:  Charles S Pavia; Maria Plummer
Journal:  Transfusion       Date:  2013-11       Impact factor: 3.157

5.  Impact of genotypic variation of Borrelia burgdorferi sensu stricto on kinetics of dissemination and severity of disease in C3H/HeJ mice.

Authors:  G Wang; C Ojaimi; R Iyer; V Saksenberg; S A McClain; G P Wormser; I Schwartz
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

6.  Ineffectiveness of tigecycline against persistent Borrelia burgdorferi.

Authors:  Stephen W Barthold; Emir Hodzic; Denise M Imai; Sunlian Feng; Xiaohua Yang; Benjamin J Luft
Journal:  Antimicrob Agents Chemother       Date:  2009-12-07       Impact factor: 5.191

7.  Efficacy of an evernimicin (SCH27899) in vitro and in an animal model of Lyme disease.

Authors:  C S Pavia; G P Wormser; J Nowakowski; A Cacciapuoti
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

8.  In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents.

Authors:  R C Johnson; C Kodner; M Russell
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

9.  Infection of Syrian hamsters with Lyme disease spirochetes.

Authors:  R C Johnson; N Marek; C Kodner
Journal:  J Clin Microbiol       Date:  1984-12       Impact factor: 5.948

10.  Persistence of Borrelia burgdorferi following antibiotic treatment in mice.

Authors:  Emir Hodzic; Sunlian Feng; Kevin Holden; Kimberly J Freet; Stephen W Barthold
Journal:  Antimicrob Agents Chemother       Date:  2008-03-03       Impact factor: 5.191

View more
  4 in total

1.  Generality of Post-Antimicrobial Treatment Persistence of Borrelia burgdorferi Strains N40 and B31 in Genetically Susceptible and Resistant Mouse Strains.

Authors:  Emir Hodzic; Denise M Imai; Edlin Escobar
Journal:  Infect Immun       Date:  2019-09-19       Impact factor: 3.441

2.  Critical analysis of a doxycycline treatment trial of rhesus macaques infected with Borrelia burgdorferi.

Authors:  Gary P Wormser; Susan O'Connell; Andrew R Pachner; Ira Schwartz; Eugene D Shapiro; Gerold Stanek; Franc Strle
Journal:  Diagn Microbiol Infect Dis       Date:  2018-06-18       Impact factor: 2.803

3.  Identification of new drug candidates against Borrelia burgdorferi using high-throughput screening.

Authors:  Venkata Raveendra Pothineni; Dhananjay Wagh; Mustafeez Mujtaba Babar; Mohammed Inayathullah; David Solow-Cordero; Kwang-Min Kim; Aneesh V Samineni; Mansi B Parekh; Lobat Tayebi; Jayakumar Rajadas
Journal:  Drug Des Devel Ther       Date:  2016-04-01       Impact factor: 4.162

4.  Diet-Induced Obesity Does Not Alter Tigecycline Treatment Efficacy in Murine Lyme Disease.

Authors:  Helena Pětrošová; Azad Eshghi; Zoha Anjum; Nataliya Zlotnikov; Caroline E Cameron; Tara J Moriarty
Journal:  Front Microbiol       Date:  2017-02-24       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.